Is a Clinical Trial Right for You?

11 December 2015 In Science, Treatment

Before the U.S. Food and Drug Administration (FDA) approves a medication or treatment for public use, it first must go through several phases of study which is known as a clinical trial. During each phase, researchers evaluate how well the treatment works and take note of any side effects.

Read More


Researcher Q&A: Dr. Vashisht Yennu Nanda

3 December 2015 In Science

MD Anderson\'s Dr. Yennu Nando explains his research for melanoma.

Read More



Research Q & A: Dr. Michael Atkins

17 November 2015 In Treatment

In the latest blog series, we talked with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Cancer Center at Georgetown University, and a member of the MRA Medical Advisory Panel.

Read More


Partnering for Cures: How Patients Can Stop Talking and Start Doing Something

6 November 2015 In Events, Melanoma Stories

Earlier this week, more than 700 thought leaders from throughout the healthcare industry gathered in New York for FasterCures’ Partnering for Cures meeting. This annual event brings together a variety of decision-makers from across diseases who are motivated by the same mission – to reduce the time and cost of...

Read More


Immunotherapy Patient Forum: 6 Reasons to Attend

27 October 2015 In Events

On November 7, the Melanoma Research Alliance is co-hosting a Patient Forum on Immunology with Global Resource for Advancing Cancer Education and the Society for Immunotherapy of Cancer. The event will be held at the National Harbor, near Washington, DC. Online registration is open through October 30.

Read More


A Father Shares His Family's Journey with Melanoma

By Skip Grinberg | 16 October 2015 In Melanoma Stories

In this guest blog post, Skip Grinberg shares his family's experience with melanoma and his drive to advance research. [caption id="attachment_1505" align="alignright" width="300"] Skip Grinberg and his extended family[/caption] Life can occasionally throw you a sharp-breaking curveball.

Read More


Melanoma and the Problem of Drug Resistance

8 October 2015 In Science

In 2002, researchers discovered a link between mutated BRAF genes and nearly half of all melanoma tumors. Since then, BRAF inhibitors—drugs that target mutated BRAF—have become a leading go-to weapon in the battle against melanoma. Their job is to cut off signals sent by altered BRAF that promote the rapid...

Read More


Researcher Q&A: Dr. Niroshana Anandasabapathy

30 September 2015 In Science

In our latest research feature, we spoke with Niroshana Anandasabapathy of Brigham and Women’s Hospital, who is the recipient of an MRA Young Investigator Award. Funded in collaboration with Brigham and Women’s Hospital, Dr. Anandasabapathy’s research is titled “Expanding immune-surveillance and immunotherapy of melanoma.” Here she explains more about her research.

Read More


The Latest on Skin Cancer Screenings

22 September 2015 In Science

To routinely screen for skin cancer or not to screen? That hot-button question still doesn’t have a solid answer. In 2009, the U.S. Preventive Services Task Force found insufficient evidence to recommend annual skin cancer screenings for all adults.

Read More


Login

×